Ranibizumab vs. pegaptanib: a cost-effectiveness study?

被引：0
|
作者：
Viroj Wiwanitkit
机构：
[1] Wiwanitkit House,
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2010年 / 248卷
关键词：
Public Health; Indirect Cost; Photodynamic Therapy; Comparative Evaluation; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1675 / 1675
相关论文
共 50 条
  • [1] Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Wiwanitkit, Viroj
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (11) : 1675 - 1675
  • [2] Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Luis Javier Hernández-Pastor
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1677 - 1677
  • [3] Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Javier Hernandez-Pastor, Luis
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (11) : 1677 - 1677
  • [4] COST-EFFECTIVENESS OF RANIBIZUMAB VS. DEXAMETHASONE IMPLANT IN DIABETIC MACULAR EDEMA
    Sezen, Cavusoglu S.
    Dokuyucu, O.
    Saylan, M.
    Burke, C.
    Mahon, R.
    Keskinaslan, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A422 - A422
  • [5] Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
    Javier Hernandez-Pastor, Luis
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (04) : 467 - 476
  • [6] Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
    Luis Javier Hernández-Pastor
    Ana Ortega
    Alfredo García-Layana
    Joaquín Giráldez
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 467 - 476
  • [7] Indoor Localization: A Cost-Effectiveness vs. Accuracy Study
    Mohebbi, Parisa
    Stroulia, Eleni
    Nikolaidis, Ioanis
    [J]. 2017 IEEE 30TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS), 2017, : 552 - 557
  • [8] Aflibercept vs. Ranibizumab: cost-effectiveness of treatment for wet age-related macular degeneration in Sweden
    Panchmatia, Hemangi R.
    Clements, Karen M.
    Hulbert, Erin
    Eriksson, Marianne
    Wittrup-Jensen, Kim
    Nilsson, Jonas
    Weinstein, Milton C.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94 (05) : 441 - 448
  • [9] Cost-effectiveness of detoxification vs. buprenorphine in pregnancy
    Willey, Alicia S.
    Walker, Allison R.
    Toffey, David E.
    Caughey, Aaron B.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S490 - S490
  • [10] Cost-Effectiveness of Detoxification vs. Methadone in Pregnancy
    Seymour-Willey, Alicia
    Sargent, James
    Toffey, David E.
    Caughey, Aaron B.
    [J]. OBSTETRICS AND GYNECOLOGY, 2018, 131 : 74S - 74S
12345